At the end of March, the Food and Drug Administration authorized a second COVID-19 booster, or fourth dose, of the Pfizer/BioNTech and Moderna vaccines for people 50 years of age and older. The idea is to shore up any flagging immunity among the most vulnerable, particularly as the omicron subvariant BA.2 sweeps across the country […]
The post Q&A on Second COVID-19 Boosters for Older People appeared first on The Atlanta Voice.
